Jianhua yu
Affiliations: | City of Hope, Duarte, CA, United States |
Google:
"Jianhua yu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shah Z, Tian L, Li Z, et al. (2024) Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer. Cell Stem Cell |
| Meng M, Zhong Z, Song L, et al. (2024) mTOR signaling promotes rapid m6A mRNA methylation to regulate NK-cell activation and effector functions. Cancer Immunology Research |
| Lu T, Ma R, Mansour AG, et al. (2024) Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non-Small Cell Lung Cancer. Cancer Immunology Research |
| Li Z, Ma R, Tang H, et al. (2024) Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death. Cell |
| Sayegh M, Ma S, Yu J. (2023) Application of natural killer immunotherapy in blood cancers and solid tumors. Current Opinion in Oncology. 35: 446-452 |
| Ma S, Caligiuri MA, Yu J. (2023) Harnessing Natural Killer Cells for Lung Cancer Therapy. Cancer Research |
| Mansour AG, Teng KY, Li Z, et al. (2023) Off-the-Shelf CAR-Engineered Natural Killer Cells Targeting FLT3 Enhance Killing of Acute Myeloid Leukemia. Blood Advances |
| Kumar A, Taghi Khani A, Duault C, et al. (2023) Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia. Journal For Immunotherapy of Cancer. 11 |
| Li X, Yan X, Wang Y, et al. (2023) The Notch signaling pathway: a potential target for cancer immunotherapy. Journal of Hematology & Oncology. 16: 45 |
| Yu J, Caligiuri MA. (2023) Viral- and tumor-reactive natural killer cells. Seminars in Immunology. 67: 101749 |